Beijing Mingtai Trading Co., Ltd.

[Name] Eltrombopag tablets
[Common name]
[Indications] r is a thrombopoietin receptor agonist suitable for the treatment of chronic immune (idiopathic ) Patients with thrombocytopenic purpura whose thrombocytopenia does not respond well to corticosteroids, immunoglobulins, or splenectomy. r Use only in patients with a degree of thrombocytopenia and clinical conditions that increase the risk of bleeding. r Should not be used with intent to normalize normal platelet counts.
[Usage and Dosage] The starting dose for most patients is three times a day. For Oriental patients or patients with moderate or severe hepatic impairment, the starting dose is three times a day. Administer on an empty stomach (1 or 2 hours before meals). r Allow an interval of hours between use and other medications, foods, or polyvalent cation (such as iron, calcium, aluminum, magnesium, selenium, and zinc) additives.
To reduce the risk of bleeding, adjust the daily dose to achieve and maintain platelet counts/. Do not exceed daily dosage. Interrupt if the platelet count does not increase after the maximum dose, if important liver function tests are abnormal, or if the platelet count reacts excessively, then discontinue.
[Adverse reactions] The most common adverse reactions (occurring in more than r patients and having a higher incidence than placebo) are: nausea, vomiting, menorrhagia, myalgia, paresthesia, cataracts, indigestion , ecchymoses, thrombocytopenia,/increase, and conjunctival hemorrhage.
[Friendly reminder]
1. All products of our company are original quality inspection reports, certificates, anti-counterfeiting labels, etc. from the original factory. The quality is absolutely reliable and new and old customers are welcome to call us to discuss and order.
2. Our company never provides free samples. Free shipping nationwide. Large quantities can be discounted and shipped on time within hours. Order hotline::! (Yang Dongling)
[Specifications] Tablets
[Packaging] Tablets/box
[Price] Yuan/box Yuan/box
[Precautions] r May cause liver toxicity. Increased serum aminotransferase levels and bilirubin were observed. Liver chemistries must be measured before starting and routinely during treatment.
[Manufacturer] GlaxoSmithKline, USA